Bioengineering Breakthrough 2025: Gene Editing and the $57 Billion Healthcare Revolution Bioengineering Breakthrough 2025: Gene Editing and the $57 Billion Healthcare Revolution 🧬 TL;DR - Executive Summary Bioengineering has reached a transformational moment in 2025, with $57.3 billion in investment driving breakthrough gene editing therapies, personalized medicine platforms, and synthetic biology applications. CRISPR-based treatments are achieving remarkable clinical success, while advances in cell therapy, tissue engineering, and precision medicine are revolutionizing healthcare delivery. The convergence of AI, genomics, and bioengineering is creating unprecedented opportunities for investors and patients alike, with the potential to cure previously incurable diseases a...